.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Cipla
Medtronic
US Army
Merck
Argus Health
Queensland Health
Farmers Insurance
Mallinckrodt
Chubb

Generated: June 26, 2017

DrugPatentWatch Database Preview

APRACLONIDINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Apraclonidine Hydrochloride, and what generic Apraclonidine Hydrochloride alternatives are available?

Apraclonidine Hydrochloride is a drug marketed by Akorn Inc and is included in one NDA.

The generic ingredient in APRACLONIDINE HYDROCHLORIDE is apraclonidine hydrochloride. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the apraclonidine hydrochloride profile page.

Summary for Tradename: APRACLONIDINE HYDROCHLORIDE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list37
Clinical Trials: see list2,245
Patent Applications: see list173
Drug Prices:see details
DailyMed Link:APRACLONIDINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: APRACLONIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc
APRACLONIDINE HYDROCHLORIDE
apraclonidine hydrochloride
SOLUTION/DROPS;OPHTHALMIC077764-001Mar 12, 2009ATRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Merck
Johnson and Johnson
Moodys
Covington
Mallinckrodt
McKinsey
US Army
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot